Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.2M | $40.4M | $52.8M | $62.7M | $49.2M | $55.3M | $65.2M | $71.3M | $74.9M | $149M |
| Revenue growth | — | 18.1% | 30.5% | 18.7% | -21.4% | 12.3% | 17.9% | 9.4% | 5.0% | 99.2% |
| Gross profit | $27.6M | $30.8M | $40.3M | $47.3M | $37.7M | $43.7M | $49.7M | $51.7M | $54.2M | $72.3M |
| Gross margin | 80.7% | 76.2% | 76.4% | 75.4% | 76.5% | 78.9% | 76.3% | 72.5% | 72.3% | 48.5% |
| Operating income | -$9.34M | -$13.6M | -$19.8M | -$26.9M | -$22.3M | -$27.6M | -$35.1M | -$30.6M | -$34.6M | -$31.4M |
| Operating margin | -27.3% | -33.7% | -37.6% | -43.0% | -45.3% | -49.8% | -53.8% | -42.8% | -46.2% | -21.1% |
| Net income | -$11.2M | -$16.1M | -$24.1M | -$29.0M | -$27.5M | -$31.2M | -$37.2M | -$30.2M | -$43.7M | -$39.0M |
| Net margin | -32.8% | -39.7% | -45.7% | -46.4% | -55.7% | -56.4% | -57.0% | -42.3% | -58.4% | -26.1% |
| EPS (diluted) | -$76.95 | -$86.34 | -$2.69 | -$1.58 | -$1.46 | -$1.22 | -$1.38 | -$1.05 | -$1.38 | -$0.59 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.54M | -$11.1M | -$20.6M | -$30.5M | -$28.4M | -$28.0M | -$30.7M | -$32.0M | -$31.0M | -$20.4M |
| Capital expenditures | $324K | $594K | $1.01M | $813K | $730K | $2.35M | $3.27M | $2.37M | $1.47M | $801K |
| Free cash flow | -$8.87M | -$11.7M | -$21.6M | -$31.3M | -$29.1M | -$30.3M | -$34.0M | -$34.4M | -$32.5M | -$21.2M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $17.0M | $29.1M | $105M | $75.7M | $49.0M | $94.1M | $70.3M | $59.7M | $18.5M | $28.1M |
| Total assets | — | $38.9M | $117M | $100M | $78.7M | $141M | $117M | $116M | $141M | $142M |
| Total liabilities | — | $44.5M | $46.0M | $52.3M | $53.2M | $56.0M | $59.8M | $81.6M | $109M | $115M |
| Long-term debt | — | $29.6M | $30.4M | $19.9M | $34.6M | $35.3M | $22.8M | $59.3M | $55.2M | $65.8M |
| Shareholders' equity | -$177M | -$193M | $71.0M | $47.9M | $25.5M | $85.2M | $57.1M | $34.2M | $27.7M | $22.4M |
| Retained earnings | — | -$197M | -$221M | -$250M | -$278M | -$309M | -$346M | -$376M | -$420M | -$459M |
| Shares (wtd avg diluted) | — | 231K | 17.7M | 18.4M | 18.8M | 25.5M | 26.9M | 28.7M | 31.7M | 66.0M |
Every figure is extracted from Neuronetics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.